Literature DB >> 22738095

Overcoming barriers to care for hepatitis C.

Paul J Clark1, Andrew J Muir.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22738095     DOI： 10.1056/NEJMp1202608

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  12 in total

1.  Screening for hepatitis C in average and high-risk populations of Qatar using rapid point-of-care testing.

Authors:  Manik Sharma; Saad Al Kaabi; Anil K John; Nazeeh Al Dweik; Hameed Ullah Wani; Ragesh Babu Thandassary; Moutaz F Derbala; Khalid Al Ejji; Khaleel Sultan; Fuad Pasic; Munnera Al Mohannadi; Rafae Yacoub; Mohd Tariq Butt; Rajvir Singh
Journal:  United European Gastroenterol J       Date:  2015-08       Impact factor: 4.623

2.  Detecting Hepatitis B and C by Combined Public Health and Primary Care Birth Cohort Testing.

Authors:  Jeanne Heil; Christian J P A Hoebe; Jochen W L Cals; Henriëtte L G Ter Waarbeek; Inge H M van Loo; Nicole H T M Dukers-Muijrers
Journal:  Ann Fam Med       Date:  2018-01       Impact factor: 5.166

3.  Will vitamin d supplementation have a role in the treatment of patients with chronic hepatitis C?

Authors:  Pankaj Puri
Journal:  J Clin Exp Hepatol       Date:  2012-12

4.  Determinants of the availability of hepatitis C testing services in opioid treatment programs: results from a national study.

Authors:  Jemima A Frimpong; Thomas D'Aunno; Lan Jiang
Journal:  Am J Public Health       Date:  2014-04-17       Impact factor: 9.308

5.  The Hepatitis C virus treatment cascade at an urban postincarceration transitions clinic.

Authors:  L Hawks; B L Norton; C O Cunningham; A D Fox
Journal:  J Viral Hepat       Date:  2016-02-09       Impact factor: 3.728

6.  Reasons for HCV non-treatment in underserved African Americans: implications for treatment with new therapeutics.

Authors:  Sarah Schaeffer; Mandana Khalili
Journal:  Ann Hepatol       Date:  2015 Mar-Apr       Impact factor: 2.400

7.  Inhibition of hepatitis C virus in chimeric mice by short synthetic hairpin RNAs: sequence analysis of surviving virus shows added selective pressure of combination therapy.

Authors:  Anne Dallas; Heini Ilves; Han Ma; Daniel J Chin; Ian Maclachlan; Klaus Klumpp; Brian H Johnston
Journal:  J Virol       Date:  2014-01-29       Impact factor: 5.103

Review 8.  Burden of pediatric hepatitis C.

Authors:  Mortada Hassan El-Shabrawi; Naglaa Mohamed Kamal
Journal:  World J Gastroenterol       Date:  2013-11-28       Impact factor: 5.742

9.  Identification of hidden key hepatitis C populations: an evaluation of screening practices using mixed epidemiological methods.

Authors:  Angelique P A Vermeiren; Nicole H T M Dukers-Muijrers; Inge H M van Loo; Frans Stals; Dirk W van Dam; Ton Ambergen; Christian J P A Hoebe
Journal:  PLoS One       Date:  2012-12-07       Impact factor: 3.240

10.  Incidence and cost of treatment-emergent comorbid events in insured patients with chronic hepatitis C virus infection: a retrospective cohort study.

Authors:  Sandhya Sapra; Eunice Chang; Michael S Broder; Gilbert L'Italien
Journal:  BMC Health Serv Res       Date:  2014-09-24       Impact factor: 2.655
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.